Data is proliferating and EHRs are a key source of data. Fewer doctors are practicing oncology, cancer is spreading, and more care is needed. Clinical research keeps growing.
Watson Health helps to support the mission of California's Valued Trust by providing the underlying analytic architecture needed to understand what’s driving cost and trend in various regions.
From IBM Research: how tiny fingernail sensors and AI can help clinicians to monitor health and disease progression
Grip strength is a useful metric in a surprisingly broad set of health issues. It has been associated with the effectiveness of medication in individuals with Parkinson's disease, the degree of cognitive function in schizophrenics, the state of an individual’s cardiovascular health, and all-cause mortality in geriatrics.
Combining real world evidence with artificial intelligence may improve visibility of treatment options for oncologists
With an impending shortage of oncologists, an exponentially growing body of literature, and a steady stream of new cancer cases, it’s no surprise that one study found significant cancer health disparities in the US.
The pressure to deliver high quality care at an affordable cost is here to stay. Whether a provider is in a fee-for-service or value-based environment, or straddling both, the relationship between cost and quality is now intimately linked.
Learn how Novant Health UVA Health System Culpeper Medical Center analyzed data to tackle their #1 cause of readmissions: sepsis.
IBM Watson Health interviewed Jonathan F. Aquino, Corporate Chief Quality and Vice Compliance Officer at AHMC Healthcare and Interim Chief Executive Officer at AHMC San Gabriel Valley Medical Center to learn more about how AHMC embraces data-driven initiatives to improve the overall quality of care.
IBM Watson® for Clinical Trial Matching uses artificial intelligence (AI) and natural language processing technology to help cancer centers identify potential candidates for trials and help clinicians find potential clinical trials for their patients.
To get some insight into how providers are handling the transition and how it has influenced their population health strategies, the HealthLeaders Media Intelligence Unit, in conjunction with IBM Watson Health, conducted the 2018 Population Health Survey.
Watson is the only AI technology tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more. In oncology, Watson is at work supporting cancer care in more than 150 hospitals in 11 countries, and a large, growing body of evidence supports the use of Watson in healthcare.